DISEASE SCANNER
Global Incurable Diseases Tracker
Idiopathic Pulmonary Fibrosis (IPF)
A chronic, progressive, and ultimately fatal lung disease characterized by scarring (fibrosis) of the lung tissue without known cause. The fibrosis is irreversible and leads to progressive decline in lung function, making breathing increasingly difficult.
3.0M
17
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1High-resolution CT (HRCT) - honeycombing pattern
- 2Pulmonary function tests (restrictive pattern)
- 3Lung biopsy (if HRCT inconclusive)
- 46-minute walk test
- 5Echocardiogram (pulmonary hypertension assessment)
Prognosis
Poor; median survival 3-5 years without transplant. Antifibrotics may extend life by 1-2 years. Acute exacerbations can be fatal. Early referral for transplant evaluation recommended.
Prevention
- Smoking cessation
- Avoid occupational exposures
- Treatment of GERD
- Vaccinations (pneumococcal, flu)
Research Status
Antifibrotic agents (pirfenidone, nintedanib) slow progression. Lung transplantation for eligible patients. Oxygen therapy and pulmonary rehabilitation for symptom management. No cure exists.
Affected Countries
Sources
- https://www.lung.org/lung-health-diseases/lung-disease-lookup/idiopathic-pulmonary-fibrosis
- https://www.ncbi.nlm.nih.gov/books/NBK48437
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.